![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Sheba Medical Center |
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00548457 |
The aim of this study is to show the frequency of endothelial dysfunction in patients suffering from ectatic coronary arteries as compared to those who have normal coronary arteries. Should this frequency be significant we would recommend initiating conventional treatment in those patients with ectatic coronary arteries as is the practice in patients with endothelial dysfunction without ectatic arteries
Condition |
Coronary Artery Ectasia |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries |
Estimated Enrollment: | 76 |
Study Start Date: | May 2006 |
Groups/Cohorts |
A |
Ages Eligible for Study: | 18 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Patients were recruited after passing cardiac catherization and diagnosed as having ectatic arteries.
Inclusion Criteria:
Contact: ARIK ASMAN, MD | 972-3-5302454 | asman@sheba.health.gov.il |
Contact: Michael Shechter, MD | 97235302617 | shechter@sheba.health.gov.il |
Israel | |||||
Heart Institute, Chaim Sheba Medical Center | Recruiting | ||||
Tel Hashomer, Israel, 52621 | |||||
Contact: Micahel Shechter, MD, MA 972-3-5302645 shechter@sheba.health.gov.il | |||||
Principal Investigator: Arik Asman, MD | |||||
Sub-Investigator: Pierre Chouraqui, MD | |||||
Sub-Investigator: Michael Shechter, MD |
Sheba Medical Center |
Study Chair: | Pierre Chouraqui, MD | Sheba Medical Center |
Responsible Party: | Sheba Medical Center ( Dr. Pierre Chouraqui ) |
Study ID Numbers: | SHEBA-06-4130-PC-CTIL |
First Received: | October 23, 2007 |
Last Updated: | January 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00548457 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
![]() |